Tularemia in Horses: Recognition and Management
Essential guide to identifying and treating rabbit fever in equine populations

Understanding the Disease Mechanism
Tularemia, commonly referred to as rabbit fever or deerfly fever, represents a significant but often overlooked zoonotic infection that affects equine populations worldwide. The disease stems from infection with Francisella tularensis, a gram-negative bacterium capable of infecting numerous mammalian species, including horses, humans, and various wildlife populations. This bacterium poses particular challenges in equine medicine due to its ability to cause severe systemic illness and its potential for rapid progression if left untreated.
The pathophysiology of tularemia in horses involves the bacterium’s capacity to evade immune surveillance and establish infection across multiple organ systems. Once the organism enters the equine body through various routes of exposure, it rapidly disseminates through the bloodstream, leading to septicemic manifestations that can prove fatal within hours or days if appropriate therapeutic intervention is not initiated promptly.
Routes of Transmission and Environmental Risk Factors
Horses can acquire tularemia through multiple exposure pathways, making prevention strategies particularly important for equine owners and managers. Understanding these transmission routes is essential for developing effective biosecurity and management protocols on equine facilities.
Arthropod-Mediated Transmission
Tick bites represent the primary transmission mechanism for equine tularemia in most geographic regions. The bacteria survive within tick vectors and transmit to horses during blood feeding. Deer flies and other biting insects can similarly transmit the organism, particularly during warmer months when arthropod populations peak. Horses with access to pastures inhabited by infected ticks face elevated exposure risk, particularly in endemic geographic areas.
Contact-Based Infection Pathways
Direct contact with infected or deceased wildlife constitutes another significant transmission route. Horses may become infected through contact with infected rabbits, hares, squirrels, and other small mammals. Additionally, if farm machinery or equipment inadvertently comes into contact with infected animal carcasses, the bacteria can become aerosolized or transferred to feed and water sources, creating indirect transmission pathways. Contaminated water supplies and feed sources present particular concern, as the organism can survive in these environments and be ingested by grazing or drinking horses.
Clinical Manifestations and Disease Presentation
Recognizing clinical signs of tularemia in horses requires understanding the typical disease progression and the variable presentations that may occur depending on the route of infection and individual horse factors.
Systemic Clinical Signs
Horses infected with tularemia characteristically develop sudden-onset fever, often exceeding 104°F, accompanied by chills and profound weakness. Progressive lethargy represents a hallmark clinical feature, with affected horses displaying marked depression and reluctance to move. Anorexia (loss of appetite) frequently develops and can contribute to secondary complications including dehydration and weight loss.
Respiratory manifestations may develop, particularly in cases where the infection progresses to pneumonic involvement. Increased respiratory rates and coughing represent common findings. Gastrointestinal symptoms including vomiting and diarrhea occur with variable frequency and severity. The respiratory and gastrointestinal signs reflect the systemic nature of the infection and the organism’s propensity to establish infection across multiple organ systems.
Regional and Localized Findings
Lymphadenopathy (enlarged lymph nodes) represents a cardinal clinical sign, with affected nodes becoming visibly swollen and often painful to palpation. The location of affected lymph nodes may reflect the route of infection—regional nodes near the bite site in cases of arthropod transmission, or more generalized lymph node enlargement in disseminated infections.
Oral and mouth ulceration occurs with notable frequency in equine tularemia cases. These ulcers may be subtle or pronounced and can impair eating and drinking. Draining abscesses may develop at infection sites or as secondary manifestations of systemic disease. The mouth ulceration and draining lesions can be particularly problematic in horses, as they may necessitate dietary modifications and increase the risk of secondary bacterial infections.
Hepatic and Splenic Involvement
Hepatosplenomegaly (enlargement of both liver and spleen) frequently occurs in advanced cases, reflecting the organism’s propensity for establishing infection within these organ systems. Icterus (yellowing of mucous membranes and sclera due to bilirubin accumulation) may develop as a consequence of hepatic compromise. These systemic manifestations indicate progression toward septicemic disease and warrant immediate therapeutic intervention.
Temporal Progression of Signs
Clinical signs typically emerge within three to five days following initial bacterial exposure, though incubation periods may extend up to fourteen days in some cases. This variable incubation period complicates early recognition and emphasizes the importance of thorough exposure history documentation. The rapidity of progression from initial signs to severe systemic illness can be dramatic, with some horses developing life-threatening septicemia within days of symptom onset.
Diagnostic Approaches and Laboratory Confirmation
Definitive diagnosis of equine tularemia requires integration of clinical findings with laboratory confirmation, as the disease’s rarity and nonspecific signs can easily lead to misdiagnosis.
Culture-Based Diagnosis
Bacterial culture from blood, tissue fluid, or biopsy samples from affected lymph nodes or lesions remains the gold standard for tularemia confirmation. However, culturing Francisella tularensis requires specialized laboratory facilities and trained personnel due to the organism’s high infectivity and potential for occupational exposure. Samples intended for culture must be submitted to laboratories equipped with appropriate biosafety infrastructure and staff experienced in handling this pathogenic organism.
Serological Examination
Serum antibody testing provides valuable diagnostic information, particularly when fourfold elevation in antibody titers is demonstrated in paired sera collected at appropriate intervals. This serological approach helps confirm infection when culture is impractical or unavailable. However, serological results must be interpreted cautiously in early infection when antibody titers may still be low.
Molecular Diagnostic Methods
Polymerase chain reaction (PCR) and other molecular techniques offer rapid confirmation of infection and can be performed by specialized diagnostic laboratories. These methods detect bacterial DNA and provide results more quickly than traditional culture methods, enabling earlier therapeutic decision-making.
Supporting Diagnostic Information
Clinical history emphasizing exposure to ticks, biting insects, or infected wildlife strengthens diagnostic suspicion. The constellation of findings—sudden fever, lymphadenopathy, mouth ulcers, and signs of systemic illness—in a horse with documented potential exposure provides strong clinical suspicion warranting treatment even before laboratory confirmation.
Treatment Protocols and Therapeutic Considerations
Early recognition and immediate initiation of appropriate antibiotic therapy dramatically improve survival outcomes in equine tularemia cases. Treatment decisions should not await laboratory confirmation when clinical suspicion is high, as the rapid progression of untreated disease can be fatal.
Primary Antibiotic Options
Streptomycin and gentamicin represent the first-line aminoglycoside antibiotics for equine tularemia treatment. These agents should be administered at recommended dosages for seven to ten days of continuous therapy. The bactericidal activity of these medications makes them particularly effective against Francisella tularensis, providing rapid bacterial elimination and clinical improvement in responsive cases.
Tetracyclines, including doxycycline, demonstrate efficacy against tularemia but require extended treatment courses to minimize relapse risk. These bacteriostatic agents require fourteen to twenty-one days of continuous administration to ensure complete bacterial elimination. The longer treatment duration reflects their mechanism of action—inhibiting bacterial protein synthesis rather than directly killing the organism.
Fluoroquinolones, such as ciprofloxacin, offer alternative options particularly in cases where aminoglycosides or tetracyclines are contraindicated. These agents typically require fourteen-day treatment courses to achieve optimal outcomes and minimize relapse incidence.
Special Considerations in Treatment Selection
Practitioners must carefully consider the limitations and restrictions on medication use in equine patients. Certain antibiotics may have regulatory restrictions or may interact with concurrent medications. The route of administration—parenteral versus oral—must be selected based on the severity of illness and the individual horse’s ability to consume oral medications. Severely ill horses may require parenteral administration to ensure adequate drug delivery.
Supportive Care Integration
Beyond antibiotic therapy, comprehensive supportive care substantially improves outcomes. Intravenous fluid therapy addresses dehydration and maintains electrolyte balance. Nutritional support through appropriate feeding strategies or supplementation helps maintain strength during recovery. Mouth care and management of oral ulcers facilitates adequate nutritional intake. Pain management and monitoring for secondary complications prevent further deterioration.
Prevention and Biosecurity Strategies
Preventing tularemia infection proves substantially more practical and cost-effective than managing established cases. Multi-faceted prevention approaches address the various transmission pathways.
Arthropod Control Measures
Regular application of approved tick and insect repellents to equine coats provides a frontline defense against arthropod-mediated transmission. Many commercial products effectively repel or kill ticks and biting flies. Pasture management aimed at reducing tick habitat—including selective brush clearing and maintenance of open grazing areas—decreases environmental tick populations. Regular inspection of horses for attached ticks and prompt removal minimizes the risk of infection transmission during blood feeding.
Wildlife and Carcass Management
Minimizing contact between horses and infected wildlife requires property management practices that discourage wildlife access to equine facilities. Proper disposal of wildlife carcasses prevents both direct contact and the environmental contamination that results from decomposition. Educating staff and owners about the risks associated with handling dead or sick animals encourages appropriate precautions and reporting of deceased wildlife on properties.
Water and Feed Supply Protection
Protecting water sources from wildlife contamination and regular maintenance of water supply systems reduces the risk of waterborne transmission. Implementation of proper sanitation protocols for feed storage and handling prevents feed contamination. Eliminating standing water and maintaining drainage systems removes breeding habitat for potential insect vectors.
Prognosis and Expected Outcomes
The prognosis for equine tularemia depends critically on the timing of diagnosis and initiation of appropriate therapy. With prompt recognition and treatment, survival rates are substantially higher than in cases where diagnosis is delayed. The mortality rate in untreated infections is considerably elevated, particularly in severe septicemic presentations. Early treatment initiation offers the best opportunity for full recovery and return to normal function.
When to Consult Your Veterinarian
Any horse presenting with unexplained fever, particularly when accompanied by lethargy, anorexia, lymph node enlargement, or oral ulceration, warrants immediate veterinary evaluation. The combination of these signs in a horse with potential exposure to ticks or wildlife should prompt rapid consultation. Early veterinary involvement enables proper diagnostic workup and swift therapeutic initiation, substantially improving outcomes and potentially preventing fatal progression.
References
- Tularemia — U.S. Centers for Disease Control and Prevention. 2024. https://www.cdc.gov/tularemia/about/index.html
- Tularemia: Causes, Symptoms, Treatment & Prevention — Cleveland Clinic. 2024. https://my.clevelandclinic.org/health/diseases/17775-tularemia
- Tularemia Fact Sheet — Minnesota Department of Health. 2024. https://www.health.state.mn.us/diseases/tularemia/tularemiafs.html
- Tularemia — Merck Manual Consumer Version. 2024. https://www.merckmanuals.com/home/infections/bacterial-infections-gram-negative-bacteria/tularemia
- Tularemia: a re-emerging tick-borne infectious disease — PubMed Central (PMC), National Center for Biotechnology Information. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7521936/
- Tularemia in animals — American Veterinary Medical Association (AVMA). 2024. https://www.avma.org/resources-tools/animal-health-and-welfare/animal-health/tularemia-animals
- Tularemia — Montana Department of Livestock, Animal Health Division. 2016. https://liv.mt.gov/_docs/Animal-Health/Newsletters/2016_09_MOH_Tularemia-1.pdf
Read full bio of medha deb








